Author(s): Louis D’Alecy, 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Non-commercial–Share.

Slides:



Advertisements
Similar presentations
Author(s): Prachi Agarwal M.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Non-commercial–Share.
Advertisements

Author(s): Don M. Blumenthal, 2010 License: Unless otherwise noted, this material is made available under the terms of the Attribution – Non-commercial.
Author(s): Michael Hortsch, Ph.D., 2010 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution.
Author(s): Michael Hortsch, Ph.D., 2010 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution.
Author(s): Louis D’Alecy, 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Non-commercial–Share.
Author(s): Gerald Abrams, M.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Non-commercial–Share.
Author(s): John Doe, MD; Jane Doe, PhD, 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution.
Author(s): John Doe, MD; Jane Doe, PhD, 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution.
Templates for editing U-M OER Materials
Author(s): Paul Conway, License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution.
Author(s): Louis D’Alecy, 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Non-commercial–Share.
Author: Jonathan Trobe, MD, 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution 3.0.
Author(s): Seetha Monrad, M.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Noncommercial–Share.
Project: Ghana Emergency Medicine Collaborative Document Title: Open Educational Resources Author(s): University of Michigan Department of Emergency Medicine.
Module: Public Health Disaster Planning for Districts Organization: East Africa HEALTH Alliance, Author(s): Dr. Roy William Mayega (Makerere.
Author(s): Brenda Gunderson, Ph.D., 2011 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Non-commercial–Share.
Author: Michael Jibson, M.D., Ph.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Share.
Author(s): MELO 3D Project Team, 2011 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution.
Author(s): Brenda Gunderson, Ph.D., 2011 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Non-commercial–Share.
Author(s): Joan Durrance, 2009 License: Unless otherwise noted, this material is made available under the terms of the Attribution - Non-commercial 3.0.
Author(s): Brenda Gunderson, Ph.D., 2011 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Non-commercial–Share.
Project: Ghana Emergency Medicine Collaborative Document Title: Seizures Author(s): Ryan LaFollette, MD (University of Cincinnati), 2013 License: Unless.
Author(s): Gerald Abrams, M.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Non-commercial–Share.
Author(s): Arno Kumagai, M.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Noncommercial–Share.
Author(s): Brenda Gunderson, Ph.D., 2011 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Non-commercial–Share.
Author(s): Brenda Gunderson, Ph.D., 2011 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Non-commercial–Share.
Author(s): Louis D’Alecy, 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Non-commercial–Share.
Author(s): Louis D’Alecy, 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Non-commercial–Share.
Author: Michael Jibson, M.D., Ph.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Share.
Author(s): Kate Saylor, 2011 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Non-commercial–Share.
Author(s): Brenda Gunderson, Ph.D., 2011 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Non-commercial–Share.
Author(s): Gerald Abrams, M.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Non-commercial–Share.
Author: John Williams, M.D., Ph.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Non-commercial–Share.
Author(s): Brenda Gunderson, Ph.D., 2011 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Non-commercial–Share.
Author(s): Paul Conway, PhD, 2010 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution.
Author(s): Gerald Abrams, M.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Non-commercial–Share.
Author(s): Brenda Gunderson, Ph.D., 2011 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Non-commercial–Share.
Author: Michael Jibson, M.D., Ph.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Share.
Author(s): Michael Hortsch, Ph.D., 2010 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution.
Author(s): Michael Hortsch, Ph.D., 2010 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution.
Author(s): Michael Hortsch, Ph.D., 2010 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution.
Author(s): Brenda Gunderson, Ph.D., 2011 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Non-commercial–Share.
Author: Michael Jibson, M.D., Ph.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Share.
Author: Michael Jibson, M.D., Ph.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Share.
Author(s): Louis D’Alecy, 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Non-commercial–Share.
Author(s): Michael Hortsch, Ph.D., 2010 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution.
Author(s): Don M. Blumenthal, 2010 License: Unless otherwise noted, this material is made available under the terms of the Attribution – Non-commercial.
Author(s): MELO 3D Project Team, 2011 License: This work is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License. To view a.
Author(s): Steve Jackson, 2009 License: Unless otherwise noted, this material is made available under the terms of the Attribution - Noncommercial - Share.
Author(s): Vic Divecha, 2011 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution-Non-commercial-Share.
Author(s): Gabriel Krieshok, Alex Pompe, 2011 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons.
Author(s): MELO 3D Project Team, 2011 License: This work is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License. To view a.
Author(s): Louis D’Alecy, 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Non-commercial–Share.
Author(s): Gerald Abrams, M.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Non-commercial–Share.
Author(s): Paul Conway, PhD, 2010 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution.
Author(s): Louis D’Alecy, 2009
Author(s): Paul Conway, PhD, 2010 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution.
Author(s): Louis D’Alecy, 2009
Author: Michael Jibson, M.D., Ph.D., 2009
Author(s): John Doe, MD; Jane Doe, PhD, 2009
Author(s): Paul Conway, PhD, 2010
Author: Robert Lyons, Ph.D., 2008
Author: Michael Jibson, M.D., Ph.D., 2009
Attribution: University of Michigan Medical School, Department of Internal Medicine License: Unless otherwise noted, this material is made available under.
1 Author(s): Rebecca W. Van Dyke, M.D., 2012
Author(s): Joan Durrance, 2009
1 Author(s): Rebecca W. Van Dyke, M.D., 2012
Attribution: University of Michigan Medical School, Department of Microbiology and Immunology License: Unless otherwise noted, this material is made available.
Attribution: Department of Neurology, 2009
Author: Michael Jibson, M.D., Ph.D., 2009
Presentation transcript:

Author(s): Louis D’Alecy, 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Non-commercial–Share Alike 3.0 License: We have reviewed this material in accordance with U.S. Copyright Law and have tried to maximize your ability to use, share, and adapt it. The citation key on the following slide provides information about how you may share and adapt this material. Copyright holders of content included in this material should contact with any questions, corrections, or clarification regarding the use of content. For more information about how to cite these materials visit Any medical information in this material is intended to inform and educate and is not a tool for self-diagnosis or a replacement for medical evaluation, advice, diagnosis or treatment by a healthcare professional. Please speak to your physician if you have questions about your medical condition. Viewer discretion is advised: Some medical content is graphic and may not be suitable for all viewers.

Citation Key for more information see: Use + Share + Adapt Make Your Own Assessment Creative Commons – Attribution License Creative Commons – Attribution Share Alike License Creative Commons – Attribution Noncommercial License Creative Commons – Attribution Noncommercial Share Alike License GNU – Free Documentation License Creative Commons – Zero Waiver Public Domain – Ineligible: Works that are ineligible for copyright protection in the U.S. (USC 17 § 102(b)) *laws in your jurisdiction may differ Public Domain – Expired: Works that are no longer protected due to an expired copyright term. Public Domain – Government: Works that are produced by the U.S. Government. (USC 17 § 105) Public Domain – Self Dedicated: Works that a copyright holder has dedicated to the public domain. Fair Use: Use of works that is determined to be Fair consistent with the U.S. Copyright Act. (USC 17 § 107) *laws in your jurisdiction may differ Our determination DOES NOT mean that all uses of this 3rd-party content are Fair Uses and we DO NOT guarantee that your use of the content is Fair. To use this content you should do your own independent analysis to determine whether or not your use will be Fair. { Content the copyright holder, author, or law permits you to use, share and adapt. } { Content Open.Michigan believes can be used, shared, and adapted because it is ineligible for copyright. } { Content Open.Michigan has used under a Fair Use determination. }

3 O 2 and CO 2 Transport M1 – Cardiovascular/Respiratory Sequence Louis D’Alecy, Ph.D. Fall 2008

4 Tuesday 11/18/08, 9:00 O 2 and CO 2 Transport 35 slides, 50 minutes 1.Describe the amount of oxygen dissolved and combined in blood. 2.Define oxygen delivery to a tissue. 3.Describe the characteristics of the oxygen-Hb saturation curve. 4.Describe the shifts produced in the oxygen-Hb saturation curve. 5.Describe the effects of anemia on oxygen content and PO 2. 6.State the three forms in which CO 2 is carried in the blood. 7.Describe the role of carbonic anhydrase in CO 2 transport. 8.Describe the chemical events associated with the uptake and release of CO 2. 9.Defines chloride shift.

5 O 2 content of blood = Dissolved + Hb bound O 2 Liquid blood Alveolar gas Source Undetermined

6 How much gas is dissolved ? A gas dissolves in a liquid in direct proportion to its partial pressure and solubility. “Henry’s Law”

7 Henry’s Law for O 22 C d O = a O 2 P O 2 C d O 2 content of dissolved O 2 mL/dL a O 2 solubility coefficient for O 2 in blood = = = mL/mm Hg/dL a O 2 The content of dissolved oxygen is equal to the product of the oxygen solubility coefficient and oxygen partial pressure. Linear straight line Relationship like y = mx. dL = 100 mL

8 Dissolved O 2 At PO 2 of 100 mmHg X you get 0.3 mL O 2 /dL dissolved oxygen in blood. With cardiac output of 5000 ml/min or 50 dL/min you would deliver (50 dL X 0.3 mL/dL) or 15 mL O 2 /min. BUT We consume 20 X that or 250 mL O 2 /min so dissolved just will not do it!! You need hemoglobin to bind and transport O 2. dL = 100 mL

9 Hemoglobin Zephyris (wikipedia),

10 Air RBC Hb-O 2 bound + O 2 dissolved Not all Hb has O 2 Plasma Dissolved only D’Alecy

11 How much O 2 is in blood? Concentration = Content mL/dL = mL/100mL = Vol% (mL of O 2 in 100 mL blood) i.e. arterial blood has 20 Vol% O 2 Content ≠ %Hb Saturation % Hb Saturation = O 2 bound to Hb X 100% O 2 capacity of Hb

12 O 2 content (with flow) determines O 2 delivery. So why do we talk about O 2 saturation? O 2 Content ≠ %Hb Saturation O 2 saturation is relatively easier to measure and O 2 content is much more difficult to measure. We need to understand the differences!!!! Thus O 2 content is more important to O 2 delivery than is O 2 saturation.

13 Hb Saturation Curve Normal Arterial Blood ~ 27 mmHg Levitzky. Pulmonary Physiology. McGraw-Hill, th ed.

14 Linear straight line relationship. Most O 2 combined. “% Hb Sat” Or Sat O 2 Content (mL / 100mL) Source Undetermined

15 Different amounts of Hb but all 100% saturated ! Hb=10 Hb=15 Hb=20 Normal blood Hb = 15 gm/dL O 2 Content (mL / 100mL) H b O 2 Saturation (%) Source Undetermined

16 DO 2 (cc/m 2 /min) CI (L/m 2 /min) Anemia or Blood loss Bartlett, Critical Care Physiology

17 i.e. ANEMIA 1. Decreased number of RBC 2. Decreased Hb content per RBC Decreased Hb concentration so that % saturation can be normal (97-100%) but O 2 content is decreased. Normal blood Hb = 15 gm/dL

18 Breathing 100% O 2. Denver ? O 2 bars? O 2 Content (mL / 100mL) Source Undetermined

19 Hemoglobin Bound Oxygen Content mL O 2 /dL C b O = S O 2 [ Hb ] Hb s 2 S O 2 = % Hb saturation [ Hb ]= hemoglobin content gm/dL blood Hb s = saturated Hb O 2 content mL O 2 /gm Hb Hb s = 1.36 mL O 2 /gm Hb = O 2 capacity = O 2 bound to Hb X 100% O 2 capacity of Hb

20 Typical Arterial Blood Oxygen Content O P 2 = 100 mm HgS O 2 = 97%[ Hb ] = 15 gm/dL C d O 2 a O 2 P O 2 = x 100 = 0.31 mL / dL Dissolved O 2 Bound O 2 C b O = S O 2 [ Hb ] Hb 2 = 0.97 x 15 x 1.36 = mL / dL Total Oxygen Content C d O 2 + C b O 2 = = 20.1 mL / dL = s

% O 2 breathing 100% O 2 100% Bound Cb O mL / dL 20.1 Dissolved Cd O Total C O H b O 2 Saturation (%) Source Undetermined

22 Breathing 100% O 2 P a O 2C a O 2 S O 2 mm HgmL / dL % Normal Hb 15 g/dl Anemia Hb 7.5 g/dl Breathing Room Air Normal Hb 15 g/dl Anemia Hb 7.5 g/dl Thus breathing 100% O 2 does not “fix” reduced oxygen transport capacity due to anemia. Content

23 DO 2 (cc/m 2 /min) CI (L/m 2 /min) Anemia or Blood loss 2X or 3X CO could compensate Bartlett, Critical Care Physiology

24 pH on O 2 Saturation of Hb Acid unloads O 2 from Hb (Bohr Effect) At any PO 2 less O 2 bound Levitzky. Pulmonary Physiology. McGraw-Hill, th ed.

25 CO 2 on O 2 Saturation of Hb CO 2 unloads O 2 from Hb (Bohr Effect) At any PO 2 less O 2 bound Levitzky. Pulmonary Physiology. McGraw-Hill, th ed.

26 Temperature on O 2 Saturation of Hb Temperature unloads O 2 from Hb At any PO 2 less O 2 bound Levitzky. Pulmonary Physiology. McGraw-Hill, th ed.

27 2,3-BPG on O 2 Saturation of Hb More 2,3-BPG unloads O 2 from Hb Lost in stored blood ~ can’t unload O 2 Levitzky. Pulmonary Physiology. McGraw-Hill, th ed.

28 Venous blood on O 2 Saturation of Hb Venous blood Venous blood unloads O 2 from Hb P 50 is PO 2 at 50% O2 saturation. Arterial blood Levitzky. Pulmonary Physiology. McGraw-Hill, th ed.

29 right shift (tissues)  H + (Bohr shift)  CO 2  temperature  2,3 BPG   H +  CO 2   temperature   2,3 BPG left shift (lungs) Summary At any PO 2 less O 2 bound. At any PO 2 more O 2 bound. Source Undetermined

30 O 2 HbO 2 H Temperature CO + 2 right shift tissue metabolism O 2 is “unloaded” in tissues D’Alecy

31 tissue ISF plasma RBC CO 2 + H 2 O H 2 CO 3 HCO H + HbO 2 O2O2 + HHb C.A. = carbonic anhydrase Cl - O2O2 O2O2 Bohr shift chloride Shifts in In tissues O 2 is “unloaded” from blood. In tissues CO 2 is “stored” in blood (for transport). Buffer Action. Source Undetermined

32 alveolus plasma RBC CO 2 + H 2 O H 2 CO 3 HCO H + HbO 2 O2O2 + HHb Cl - O2O2 O2O2 Haldane shift chloride Shift out HCO 3 - In lungs CO 2 is “unloaded” from blood. In lungs O 2 is “stored” in blood. C.A. = carbonic anhydrase Source Undetermined

33 C d x = a x P x C d x = dissolved gas content mL/dL =0.003 mL / mm Hg /dL a O 2 =0.06 mL / mm Hg /dL a CO 2 How is CO 2 Transported? CO 2 is about 20 x more soluble than O 2 But still only 5% (art.) to 10% (ven.) of transport is dissolved!! The content of dissolved gas (C dx ) is the product of the solubility coefficient (a x ) and the partial pressure of the gas (P x ).

34 Most Some H + + Hb-NHCOO - = Hb + CO 2 + H 2 O = H + + HCO3 - Carbonic Anhydrase Levitzky. Pulmonary Physiology. McGraw-Hill, th ed.

35 Reduced (de-ox)Hb binds more CO 2 than HbO 2 Source Undetermined

36 Source Undetermined

37 Reduced (de-ox)Hb binds more CO 2 than HbO 2, venous blood can carry more CO 2 then arterial blood. Venous blood Arterial blood Venous Arterial Levitzky. Pulmonary Physiology. McGraw-Hill, th ed.

38 right shift (tissues)  H + (Bohr shift)  CO 2  temperature  2,3 BPG   H +  CO 2   temperature   2,3 BPG left shift (lungs) Summary At any PO 2 less O 2 bound. At any PO 2 more O 2 bound. Source Undetermined

Slide 5: Source Undetermined Slide 9: GFDL, Zephyris (wikipedia), Slide 10: D’Alecy Slide 13: Levitzky. Pulmonary Physiology. McGraw-Hill, th ed. Slide 14: Source Undetermined Slide 15: Source Undetermined Slide 16: Bartlett, Critical Care Physiology Slide 18: Source Undetermined Slide 21: Source Undetermined Slide 23: Bartlett, Critical Care Physiology Slide 24: Levitzky. Pulmonary Physiology. McGraw-Hill, th ed. Slide 25: Levitzky. Pulmonary Physiology. McGraw-Hill, th ed. Slide 26: Levitzky. Pulmonary Physiology. McGraw-Hill, th ed. Slide 27: Levitzky. Pulmonary Physiology. McGraw-Hill, th ed. Slide 28: Levitzky. Pulmonary Physiology. McGraw-Hill, th ed. Slide 29: Source Undetermined Slide 30: D’Alecy Slide 31: Source Undetermined Slide 32: Source Undetermined Slide 34: Levitzky. Pulmonary Physiology. McGraw-Hill, th ed. Slide 35: Source Undetermined Slide 36: Source Undetermined Slide 37: Levitzky. Pulmonary Physiology. McGraw-Hill, th ed. Slide 38: Source Undetermined Additional Source Information for more information see: